Outcomes of tafasitamab and lenalidomide in large B-cell lymphoma based on prior CD19-directed CAR T exposure
基于既往CD19靶向CAR-T细胞治疗史,评估tafasitamab和来那度胺治疗大B细胞淋巴瘤的疗效。
期刊:Hemasphere
影响因子:14.6
doi:10.1002/hem3.70253
Merrill, Mwanasha H; Redd, Robert A; Lambert, Nicholas; Caimi, Paolo F; Pullarkat, Priyanka; Godby, Richard C; Bond, David A; Wehmeyer, Graham T; Romancik, Jason; Amoozgar, Behzad; Leslie, Lori; Nastoupil, Loretta J; Crombie, Jennifer L; Abramson, Jeremy S; Khurana, Arushi; Nowakowski, Grzegorz S; Maddocks, Kami; Rutherford, Sarah C; Kahl, Brad; Okwali, Michelle; Buege, Michael J; Batlevi, Connie L; Armand, Philippe; Salles, Gilles; Qualls, David A
B细胞
T细胞
淋巴瘤
T细胞
细胞生物学
CD19
免疫/内分泌